BSE Live
Dec 05, 16:00Prev. Close
39.59
Open Price
40.39
Bid Price (Qty.)
40.13 (4)
Offer Price (Qty.)
40.13 (191)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 6.34 | 2.32 | 1.96 | 2.55 | 2.13 | |
| Less: Excise/Sevice Tax/Other Levies | 1.89 | 0.95 | 0.40 | 0.01 | 0.03 | |
| Revenue From Operations [Net] | 4.45 | 1.37 | 1.56 | 2.54 | 2.10 | |
| Total Operating Revenues | 11.85 | 5.66 | 5.34 | 5.14 | 4.83 | |
| Other Income | 0.01 | 0.04 | 0.11 | 0.07 | 0.19 | |
| Total Revenue | 11.86 | 5.70 | 5.46 | 5.20 | 5.02 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 3.33 | 1.16 | 0.89 | 0.95 | 1.64 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.33 | -0.17 | 0.07 | 0.09 | 0.11 | |
| Employee Benefit Expenses | 4.40 | 1.96 | 1.28 | 1.09 | 1.15 | |
| Finance Costs | 0.00 | 0.00 | 0.04 | 0.01 | 0.00 | |
| Depreciation And Amortisation Expenses | 1.48 | 0.96 | 0.74 | 0.47 | 0.45 | |
| Other Expenses | 2.90 | 1.06 | 1.50 | 1.54 | 0.74 | |
| Total Expenses | 11.79 | 4.97 | 4.51 | 4.14 | 4.09 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.07 | 0.72 | 0.95 | 1.06 | 0.92 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.57 | |
| Profit/Loss Before Tax | 0.07 | 0.72 | 0.95 | 1.06 | 0.35 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.15 | 0.18 | 0.39 | 0.08 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.14 | 0.12 | 0.24 | 0.16 | 0.15 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.14 | 0.26 | 0.42 | 0.56 | 0.23 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -0.07 | 0.46 | 0.53 | 0.50 | 0.12 | |
| Profit/Loss From Continuing Operations | 0.04 | 0.46 | 0.53 | 0.50 | 0.12 | |
| Profit/Loss For The Period | 0.04 | 0.46 | 0.53 | 0.50 | 0.12 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 0.23 | 2.95 | 3.36 | 3.21 | 0.76 | |
| Diluted EPS (Rs.) | 0.23 | 2.95 | 3.36 | 3.21 | 0.76 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 5.00 | 5.00 | 5.00 | 0.00 |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y